highly significantp = 0.005
MDR‐TB prevalence was substantially higher in the TB–T2DM group (10 cases, 22.73%) compared to the nondiabetic group (nine cases, 6.52%) with statistically highly significant ( p = 0.005).
MDR‐TB prevalence was substantially higher in the TB–T2DM group (10 cases, 22.73%) compared to the nondiabetic group (nine cases, 6.52%) with statistically highly significant ( p = 0.005).